FDA reviewing heart risks of Glaxo di...

FDA reviewing heart risks of Glaxo diabetes pill

There are 2 comments on the News Talk Florida story from Apr 12, 2013, titled FDA reviewing heart risks of Glaxo diabetes pill. In it, News Talk Florida reports that:

The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia.

Join the discussion below, or Read more at News Talk Florida.


Alachua, FL

#1 Apr 12, 2013
Not enough research. Too many deaths and heart failures. All profits plus penalty and any bonus since 2007 for the CEO plus interest should be taken by the government

Winnipeg, Canada

#2 Apr 13, 2013
Once again FDA APPROVED pharma is maiming consumers. And only after this EXPERIMENTATION on unsuspecting consumers, does that fact proper safety studies were not done. FDA approval means Pharma can use these consumers as free test subjects, so Pharma doesn't need to do expensive safety studies at all. The Bush government under George DUBYA gave vaccine makers blanket protection from all types of litigation which was recinded under Obama. But it shows who government protects from who.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Diabetes Discussions

Title Updated Last By Comments
Medtronic MMT-399 4 hr LenNJ 1
Medtronic Reservoirs For Sale 22 hr jaynepearls 1
News Exercise regimens offer little benefit for one ... 23 hr Art 4
G4 sensors and Insulet Pods Mon Diabeticmomof4 24
Medtronic MMT-332A Reservoirs (Oct '12) Mon Diabeticmomof4 5
In Search Of Dexcom G4 Receiver Mon Diabeticmomof4 4
G4 Platinum (Jan '15) Sun tamm 50
More from around the web